Clinical Trial Update: Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis [Phase 3]

View source ↗

Summary

Phase 3 trial update on the safety and efficacy of AIN457 in patients with quiescent non-infectious uveitis; the study was terminated and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Uveitis

Drugs mentioned

• AIN457

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Non-infectious Uveitis | Phase 3 | Status: TERMINATED | Results posted: 2015-11-05